Value-Based Payment Experiments For Drugs To Be Key Focus For CMMI, Director Says

Recently-installed Center for Medicare and Medicaid Innovation Chief Adam Boehler says payment lab will play a role in the Administration’s overall approach to lowering prescription drug costs.

Bundle of money and pack of medication tablets or drug pills, close-up. Expensive health care concept, selective focus

The new director of the US Center for Medicare and Medicaid Innovation is renewing the unit's commitment to experimenting with reimbursement designs for pharmaceuticals.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access